HM13 and gastric cancer: SPP has been shown to be strongly correlated with OS in nonsmall cell lung cancer [25], gastric cancer [26], and HCC [27]; in these malignancies, the TTP or progression-free survival (PFS) becomes weaker as the proportion of SPP to OS increases.